Ƶ

Public Health & Policy

FDA General

More in FDA General

Novel Targeted Drug Approved for Stomach Cancers

Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy

Oct 18, 2024
FDA APPROVED FDA has approved zolbetuximab (Vyloy) over a computer rendering of a monoclonal antibody and cancer cells.
Drugmaker Pulls Trodelvy's Bladder Cancer Approval

In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy

Oct 18, 2024
A photo of the packaging and vial of Trodelvy.
Serious Battery Issue Prompts Medtronic Insulin Pump Recall

Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases

Oct 18, 2024
A photo of a man holding a Medtronic MiniMed 780G pump.
Continuous Parkinson's Disease Therapy Wins FDA Nod

Round-the-clock infusion delivers carbidopa and levodopa pro-drugs

Oct 17, 2024
FDA APPROVED foscarbidopa and foslevodopa (Vyalev) over a computer rendering of Lewy bodies.
Three States Renew Effort to Reduce Access to Abortion Pill Mifepristone

Lawsuit aims to require three in-person doctor visits, bar drug's use after 7 weeks of pregnancy

Oct 17, 2024
A photo of a mifepristone tablet in a patient’s hand during a visit to a clinic in Kansas City, KS.
Opinion
The Supreme Court's Open Season on Public Health Agencies

"I just had this reverence for the court. I don't anymore," says Lawrence Gostin, JD

Oct 16, 2024
image
Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers

During harvesting and processing, the seeds can become coated with the opium

Oct 12, 2024
 A photo of a spoon full of poppy seeds and poppy capsules in the background.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

First once-weekly subcutaneous prophylactic option for hemophilia B

Oct 11, 2024
FDA APPROVED marstacimab-hncq (Hympavzi) over a computer rendering of a leaking blood vessel.
Elamipretide for Barth Syndrome Survives FDA Advisory Vote

Panelists acknowledge difficulty generating stronger data in ultra-rare disease

Oct 11, 2024
FDA ADCOMM elamipretide hydrochloride injection over a computer rendering of mitochondria.
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer

Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease

Oct 10, 2024
inavolisib (Itovebi) over a computer rendering of advanced breast cancer.
FDA's Promised Guidance on Pulse Oximeters Unlikely to End Decades of Racial Bias

Devices three times as likely to miss dangerously low blood oxygen in Black patients

Oct 10, 2024
A closeup photo of a pulse oximeter on a man’s finger.
FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndrome

Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease

Oct 09, 2024
FDA ADCOMM elamipretide hydrochloride injection over a computer rendering of mitochondria.
How Did Public Health Become a Public Enemy at the Supreme Court?

Conservative majority is "buying into" anti-science attitudes, warns Lawrence Gostin, JD

Oct 09, 2024
image
Opinion
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved?

I anticipate benefits outweighing potential risks in only a select few situations

Oct 06, 2024
A photo of a man holding a Saxenda injection pen.
More in FDA General